Comprehensive Pharmacology Study Guide on Antidepressants and Antipsychotic Drugs

Pathophysiology and General Concepts of Depression

  • Neurotransmitter Alterations in Depression:

    • Depression is characterized by decreased synaptic concentrations of monoamine neurotransmitters.
    • The primary neurotransmitters with reduced levels in depression are noradrenaline (NANA) and serotonin (5HT5HT).
  • Monoamine Reuptake Inhibition:

    • Agents that inhibit the reuptake of both serotonin (5HT5HT) and noradrenaline (NANA) into presynaptic nerve terminals are classified primarily as Tricyclic Antidepressants (TCAs).

Tricyclic Antidepressants (TCAs)

  • Pharmacological Properties and Receptor Profile:

    • In addition to inhibiting the reuptake of 5HT5HT and NANA, TCAs possess prominent secondary receptor-blocking properties.
    • TCAs exhibit significant anticholinergic activity (muscarinic receptor blockade).
    • TCAs exhibit significant α\alpha-adrenergic receptor-blocking properties (α\alpha-blockade).
    • TCAs also exhibit anti-histaminic (H1H_1) blocking properties.
  • Chemical Classification of Tricyclic Antidepressants:

    • Dibenzoazepine Derivatives:
    • Representative agents include Imipramine and Desipramine.
    • Therapeutic dosing range: 50–200 mg50\text{--}200\,mg.
    • Dibenzocycloheptene Derivatives:
    • Representative agents include Amitryptyline and Nortryptyline.
    • Dibenzoxazepine Derivatives:
    • Representative agent: Amoxapine.
  • Adverse Effects of TCAs:

    • Weight gain.
    • Hypotension (orthostatic/postural hypotension secondary to α\alpha-adrenergic blockade).
    • Reflex tachycardia (resulting from peripheral vasodilation and anticholinergic vagolytic effects).
  • Specific Therapeutic Applications of TCAs:

    • Enuresis (Bedwetting): Nocturnal bedwetting in children is controlled using a low dose of Imipramine (50 mg50\,mg).

Selective Serotonin Reuptake Inhibitors (SSRIs)

  • Drug Class Overview:

    • SSRIs selectively inhibit the reuptake of serotonin (5HT5HT) into the presynaptic neuron without significantly affecting noradrenaline reuptake.
    • Individual drugs within this class:
    • Fluoxetine
    • Fluvoxamine
    • Sertaline
    • Citalopram
    • Paroxetine
  • Receptor Selectivity and Tolerability:

    • SSRIs feature minimum anticholinergic activity.
    • SSRIs feature minimum α\alpha-blocking activity.
    • SSRIs feature minimum anti-histamine receptor-blocking activity.
    • This reduced off-target affinity results in an improved side-effect profile compared to classic TCAs.
  • Indications:

    • Drug of Choice (DOC) for Obsessive-Compulsive Disorder (O.C.D.): SSRIs (e.g., Fluoxetine, Paroxetine, etc.).

Monoamine Oxidase Inhibitors (MAOIs) and the Cheese Reaction

  • Classification of MAO Inhibitors:

    • Selective MAO-A Inhibitors:
    • Moclobemide
    • Clorgyline
    • Non-selective MAO Inhibitors:
    • Isocarboxazide
    • Phenelzine
    • Tranylcypromine
  • The Cheese Reaction:

    • Precipitating Agents: Likely occurs following the ingestion of tyramine-rich foods (such as aged cheese) during treatment with MAO inhibitors.
    • Clinical Presentation: Manifests as severe, acute hypertension (hypertensive crisis) due to the failure to metabolize exogenous tyramine, causing systemic catecholamine release.
    • Treatment Protocol: The severe hypertension in cheese reactions is treated pharmacologically with:
    • Phentolamine (an α\alpha-adrenergic antagonist)
    • Labetolol (a mixed α\alpha/β\beta-adrenergic antagonist)

Atypical and Other Specific Antidepressants

  • Selective Noradrenaline Reuptake Inhibitors (Selective NRIs):

    • Specific agents include Nisoxetine and Reboxetine.
  • Serotonin-Modulating Antidepressants:

    • Trazodone: Notable for causing priapism (prolonged, painful penile erection) as a specific adverse drug reaction.
  • Presynaptic α2\alpha_2-Adrenoceptor Antagonists:

    • Presynaptic α2\alpha_2 blockade acts to enhance monoaminergic transmission in depression.
    • Representative agents include Mainserin and Mirtazapine.
    • Mainserin: Notable adverse effect is bone marrow depression (agranulocytosis/aplastic anemia).
    • Mirtazapine Mechanism of Action:
    • Blocks presynaptic α2\alpha_2-adrenergic auto- and hetero-receptors.
    • Concurrently blocks serotonergic 5HT25HT_2 and 5HT35HT_3 receptors.
  • Bupropion:

    • Exhibits distinct central nervous system amphetamine-like excitatory properties.
    • Indicated for clinical use in smoking cessation regimens.

Pathophysiology and Terminology of Psychosis

  • General Terminology:

    • Antipsychotics are also designated clinically as neuroleptics or major tranquilizers.
  • Neurochemical Basis of Psychosis:

    • Psychosis is associated with an increased level of dopamine (DADA), specifically concentrated within the mesolimbic area of the brain.
  • Psychiatric Symptoms:

    • Hallucination: Defined as a sensory perception of something that does not exist in the external environment.
    • Delusion: Defined as a false personal belief that is firmly sustained and resistant to confrontation with actual facts or contrary evidence.

Classification and Mechanisms of Antipsychotic Drugs

  • Typical Antipsychotics:

    • First-generation agents that primarily block dopamine D2D_2 receptors in the central nervous system.
  • Atypical Antipsychotics:

    • Second-generation agents that block both dopamine D2D_2 receptors and serotonin 5HT25HT_2 receptors (dual D2+5HT2D_2 + 5HT_2 receptor blockade).

Chemical Derivatives of Phenothiazine Antipsychotics

  • Propylamino Phenothiazine Derivatives (Aliphatic Side Chain):

    • Promazine
    • CPZ (Chlorpromazine)
    • Triflupromazine
  • Piperidine Phenothiazine Derivatives:

    • Thioridazine
    • Mesoridazine
  • Propylpiperazine Derivatives (Piperazine Phenothiazines):

    • Prochlorperazine
    • Triflupromazine
    • Perphenazine